Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elmira Ebrahimi
What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?
Archives of Breast Cancer
Related publications
Lurbinectedin Is Active in Patients With BRCA1/2 Mutant Breast Cancer
Cancer Discovery
Oncology
Body Weight and Risk of Breast Cancer in BRCA1/2 Mutation Carriers
Breast Cancer Research and Treatment
Cancer Research
Oncology
Physical Activity and the Risk of Breast Cancer in BRCA1/2 Mutation Carriers
Breast Cancer Research and Treatment
Cancer Research
Oncology
Performance of BRCA1/ 2 Mutation Prediction Models in Male Breast Cancer Patients
Clinical Genetics
Genetics
RASSF1A Polymorphism A133S Is Associated With Early Onset Breast Cancer in BRCA1/2 Mutation Carriers
Cancer Research
Cancer Research
Oncology
Seventeen Years After BRCA1: What Is the BRCA Mutation Status of the Breast Cancer Patients in Africa? – A Systematic Review
SpringerPlus
Multidisciplinary
A Patient Decision Aid for Risk-Reducing Surgery in Premenopausal BRCA1/2 Mutation Carriers: Development Process and Pilot Testing
Health Expectations
Environmental
Public Health
Occupational Health
BRCA1 (185delAG) Mutation Among Egyptian Breast Cancer Female Patients
Journal of High Institute of Public Health
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
JAMA - Journal of the American Medical Association
Medicine